DE69630039D1 - Verfahren zur herstellung gm2-spezifischer antikörper - Google Patents

Verfahren zur herstellung gm2-spezifischer antikörper

Info

Publication number
DE69630039D1
DE69630039D1 DE69630039T DE69630039T DE69630039D1 DE 69630039 D1 DE69630039 D1 DE 69630039D1 DE 69630039 T DE69630039 T DE 69630039T DE 69630039 T DE69630039 T DE 69630039T DE 69630039 D1 DE69630039 D1 DE 69630039D1
Authority
DE
Germany
Prior art keywords
producing
specific antibodies
antibodies
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630039T
Other languages
English (en)
Other versions
DE69630039T2 (de
Inventor
Gerd Ritter
J Old
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research New York
Publication of DE69630039D1 publication Critical patent/DE69630039D1/de
Application granted granted Critical
Publication of DE69630039T2 publication Critical patent/DE69630039T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69630039T 1995-06-16 1996-06-11 Verfahren zur herstellung gm2-spezifischer antikörper Expired - Fee Related DE69630039T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US491310 1995-06-16
US08/491,310 US6057115A (en) 1995-06-16 1995-06-16 Process for producing GM2 specific antibodies
PCT/US1996/009824 WO1997000445A1 (en) 1995-06-16 1996-06-11 Process for producing gm2 specific antibodies

Publications (2)

Publication Number Publication Date
DE69630039D1 true DE69630039D1 (de) 2003-10-23
DE69630039T2 DE69630039T2 (de) 2004-08-05

Family

ID=23951660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630039T Expired - Fee Related DE69630039T2 (de) 1995-06-16 1996-06-11 Verfahren zur herstellung gm2-spezifischer antikörper

Country Status (7)

Country Link
US (2) US6057115A (de)
EP (1) EP0842428B1 (de)
JP (2) JP3286845B2 (de)
AU (1) AU705699B2 (de)
CA (1) CA2224460C (de)
DE (1) DE69630039T2 (de)
WO (1) WO1997000445A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027205A1 (en) * 1998-11-12 2000-05-18 United States Government As Represented By The Secretary Of The Navy A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
EP2275541B1 (de) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Verfahren zur Steuerung der Aktivität von immunologisch funktionellen Molekülen
CA2733819A1 (en) * 1999-12-30 2001-07-12 Judith K. Gwathmey Iron chelator delivery system
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
GB0414055D0 (en) * 2004-06-23 2004-07-28 Univ Edinburgh Specific binding members and uses thereof
CN104151372B (zh) * 2014-07-30 2017-05-17 湖南利诺生物药业有限公司 单唾液酸四已糖神经节苷脂gm1原料的制备方法
JP2017044705A (ja) * 2016-11-21 2017-03-02 国立大学法人北海道大学 糖鎖アレイ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
GB8422651D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
US5169757A (en) * 1987-05-20 1992-12-08 Carleton University Antibodies or antigens bound to a macroporous hydrophobic synthetic polymer cloth for immunological techniques
US5229289A (en) * 1988-03-11 1993-07-20 The Biomembrane Institute Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates
CA1337403C (en) * 1988-03-28 1995-10-24 Biomembrane Institute (The) Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5240833A (en) * 1989-01-30 1993-08-31 The Biomembrane Institute Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides
US5258178A (en) * 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens

Also Published As

Publication number Publication date
US6057115A (en) 2000-05-02
JPH11503172A (ja) 1999-03-23
EP0842428B1 (de) 2003-09-17
WO1997000445A1 (en) 1997-01-03
AU705699B2 (en) 1999-05-27
US5854007A (en) 1998-12-29
EP0842428A1 (de) 1998-05-20
CA2224460C (en) 2002-10-01
EP0842428A4 (de) 2001-05-02
JP3286845B2 (ja) 2002-05-27
CA2224460A1 (en) 1997-01-03
AU6108696A (en) 1997-01-15
JP2002205999A (ja) 2002-07-23
DE69630039T2 (de) 2004-08-05

Similar Documents

Publication Publication Date Title
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
DE69602166D1 (de) Verfahren zur herstellung von methanol
DE69331269D1 (de) Verfahren zur herstellung von antikörpern
DE69613486D1 (de) Verbessertes verfahren zur herstellung von bisphenolen
DE69701594D1 (de) Verfahren zur herstellung von polysilazan
DE69628421D1 (de) Verfahren zur herstellung von tetraazacycloalkanen.
DE69606871D1 (de) Verfahren zur herstellung überzogener gegenstände
DE69511290D1 (de) Verfahren zur herstellung von halohydroxypropyltrialkylammoniumhalogeniden
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
DE69628203D1 (de) Verfahren zur herstellung von phenylimidazolin-derivaten
ATE303134T1 (de) Verfahren zur herstellung von flavano-lignan- zubereitungen
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
DE69607966D1 (de) Verfahren zur herstellung hydroxy-substituierter acetylenischer biphenyle
ATE181554T1 (de) Verfahren zur herstellung von n- phosphonomethylglyzin
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE69601993D1 (de) Verfahren zur herstellung von doxorubicin
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
DE69625466D1 (de) Verfahren zur herstellung von polyethylennaphathalat
DE69615836D1 (de) Verfahren zur herstellung von boroxyd
DE69630039D1 (de) Verfahren zur herstellung gm2-spezifischer antikörper
DE59509620D1 (de) Verfahren zur herstellung von acyloinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee